The ameliorating effect of suvorexant, a dual orexin receptor antagonist, on glucose metabolism in type 2 diabetic db/db mice

被引：0
|
作者：
Tsuneki, H. [1 ]
Kon, K. [1 ]
Wada, T. [1 ]
Sasaoka, T. [1 ]
机构：
[1] Univ Toyama, Dept Clin Pharmacol, Toyama, Japan
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
232
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [21] Effect on Cognitive Performance of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem
    Landry, Ishani
    Hall, Nancy
    Aluri, Jagadeesh
    Filippov, Gleb
    Reyderman, Larisa
    Setnik, Beatrice
    Moline, Margaret
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 253 - 253
  • [22] Protective Effect of Ipragliflozin on Pancreatic Islet Cells in Obese Type 2 Diabetic db/db Mice
    Takasu, Toshiyuki
    Takakura, Shoji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2018, 41 (05) : 761 - 769
  • [23] Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice
    He, Qing
    Pu, Jun
    Yuan, Ancai
    Yao, Tianbao
    Ying, Xiaoying
    Zhao, Yichao
    Xu, Longwei
    Tong, Huan
    He, Ben
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [24] Anti-diabetic Effects of Adlay Protein in Type 2 Diabetic db/db Mice
    Watanabe, Mitsuru
    Kato, Masako
    Ayugase, Jun
    FOOD SCIENCE AND TECHNOLOGY RESEARCH, 2012, 18 (03) : 383 - 390
  • [25] Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice
    Fang Zhou
    Keisuke Furuhashi
    Myoung Jin Son
    Miku Toyozaki
    Fumiaki Yoshizawa
    Yutaka Miura
    Kazumi Yagasaki
    Cytotechnology, 2017, 69 : 493 - 502
  • [26] Anti-Diabetic Atherosclerosis Effect of Prunella vulgaris in db/db Mice with Type 2 Diabetes
    Hwang, Sun Mi
    Kim, Jin Sook
    Lee, Yun Jung
    Yoon, Jung Joo
    Lee, So Min
    Kang, Dae Gill
    Lee, Ho Sub
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2012, 40 (05): : 937 - 951
  • [27] Antidiabetic effect of enterolactone in cultured muscle cells and in type 2 diabetic model db/db mice
    Zhou, Fang
    Furuhashi, Keisuke
    Son, Myoung Jin
    Toyozaki, Miku
    Yoshizawa, Fumiaki
    Miura, Yutaka
    Yagasaki, Kazumi
    CYTOTECHNOLOGY, 2017, 69 (03) : 493 - 502
  • [28] Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice
    Qing He
    Jun Pu
    Ancai Yuan
    Tianbao Yao
    Xiaoying Ying
    Yichao Zhao
    Longwei Xu
    Huan Tong
    Ben He
    Cardiovascular Diabetology, 13
  • [29] Anti-diabetic effect of amorphastilbol through PPARα/γ dual activation in db/db mice
    Lee, Woojung
    Ham, Jungyeob
    Kwon, Hak Cheol
    Kim, Yong Kee
    Kim, Su-Nam
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 432 (01) : 73 - 79
  • [30] Treatment of type 2 diabetic db/db mice with a novel PPARγ agonist improves cardiac metabolism but not contractile function
    Carley, AN
    Semeniuk, LM
    Shimoni, Y
    Aasum, E
    Larsen, TS
    Berger, JP
    Severson, DL
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (03): : E449 - E455
12345